Key result
Patients diagnosed with acrodermatitis chronica atrophicans between 2005 and 2018 presented with fewer constitutional symptoms (52.5% vs 80.3%) and less skin atrophy compared to those diagnosed between 1991 and 2004.
Why the study?
Information on large groups of patients with acrodermatitis chronica atrophicans was limited.
Cohort (n=693)
No
Acrodermatitis chronica atrophicans is typically caused by Borrelia afzelii and predominantly affects older women, with earlier diagnosis in recent years leading to less frequent presentation of skin atrophy.
BACKGROUND: Information on large groups of patients with acrodermatitis chronica atrophicans (ACA) is limited. METHODS: We assessed clinical and microbiological characteristics of patients with ACA diagnosed at a single medical centre and compared findings in periods 1991-2004 vs. 2005-2018. The cohort is representative of Slovenian ACA patients. RESULTS: We assessed 693 patients: 461 females and 232 males, with median age of 64 years. Median duration of ACA before diagnosis was 12 months. In all but 2 patients, the skin lesions were located on extremities, more often on the lower (70.0%) than the upper (45.2%), bilaterally in 42.4%. Reddish-blue discoloration, swelling, thinning and wrinkling of skin were present in 95.2%, 28.1%, 46.4% and 20.5% of patients, respectively. Overall, 64.4% of patients reported constitutional symptoms, 23.1% had local symptoms, and 20.8% had symptoms/signs of peripheral neuropathy. Nodules, arthritis, joint deformity, muscle atrophy and paresis were rare (<3%). Borreliae were isolated from 200/664 (30.1%) skin samples; 92.8% were Borrelia afzelii. B. garinii and B. burgdorferi s.s. were more often isolated from the skin of male patients (OR = 4.17) and from those with arthropathy (OR = 11.74). Patients included in the more recent period were older, complained less often of constitutional symptoms but more often of local symptoms, and more often had local swelling but less often skin atrophy and bilateral involvement, probably as a consequence of earlier diagnosis. CONCLUSIONS: ACA, typically caused by B. afzelii, usually affects older women. Clinical presentation depends on the duration of illness and probably on the Borrelia species causing the disease.
No takes yet. Share an insight, caveat, or question.
Ogrinc et al. (2021) conducted a cohort in Acrodermatitis chronica atrophicans (n=693). Diagnosis in recent period (2005-2018) vs. Diagnosis in earlier period (1991-2004) was evaluated on Constitutional symptoms at presentation (p=<0.001). Patients diagnosed with acrodermatitis chronica atrophicans between 2005 and 2018 presented with fewer constitutional symptoms (52.5% vs 80.3%) and less skin atrophy compared to those diagnosed between 1991 and 2004.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: